Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes

Sekeres MA, Peterson B, Dodge RK, Mayer RJ, Moore JO, Lee EJ et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood 2004; 103: 4036–4042.

Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK et al. Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 2009; 27: 2157–2162.

Bradley CJ, Given CW, Roberts C . Disparities in cancer diagnosis and survival. Cancer 2001; 91: 178–188.

Ma X . Epidemiology of myelodysplastic syndromes. Am J Med 2012; 125 (7 Suppl): S2–S5.

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454–2465.